Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Gene expression profiling in bladder cancer identifies potential therapeutic targets.

Authors:
Syed A Hussain Daniel H Palmer Wing-Kin Syn Joseph J Sacco Richard M D Greensmith Taha Elmetwali Vijay Aachi Bryony H Lloyd Puthen V Jithesh John Arrand Darren Barton Jawaher Ansari D Ross Sibson Nicholas D James

Int J Oncol 2017 Apr 2;50(4):1147-1159. Epub 2017 Mar 2.

School of Cancer Sciences, University of Birmingham, Birmingham B15 2TT, UK.

Despite advances in management, bladder cancer remains a major cause of cancer related complications. Characterisation of gene expression patterns in bladder cancer allows the identification of pathways involved in its pathogenesis, and may stimulate the development of novel therapies targeting these pathways. Between 2004 and 2005, cystoscopic bladder biopsies were obtained from 19 patients and 11 controls. These were subjected to whole transcript-based microarray analysis. Unsupervised hierarchical clustering was used to identify samples with similar expression profiles. Hypergeometric analysis was used to identify canonical pathways and curated networks having statistically significant enrichment of differentially expressed genes. Osteopontin (OPN) expression was validated by immunohistochemistry. Hierarchical clustering defined signatures, which differentiated between cancer and healthy tissue, muscle-invasive or non-muscle invasive cancer and healthy tissue, grade 1 and grade 3. Pathways associated with cell cycle and proliferation were markedly upregulated in muscle-invasive and grade 3 cancers. Genes associated with the classical complement pathway were downregulated in non-muscle invasive cancer. Osteopontin was markedly overexpressed in invasive cancer compared to healthy tissue. The present study contributes to a growing body of work on gene expression signatures in bladder cancer. The data support an important role for osteopontin in bladder cancer, and identify several pathways worthy of further investigation.

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo.2017.3893DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363876PMC
April 2017

Publication Analysis

Top Keywords

bladder cancer
20
invasive cancer
12
gene expression
12
healthy tissue
12
cancer
10
hierarchical clustering
8
non-muscle invasive
8
cancer healthy
8
bladder
6
pathways
5
signatures differentiated
4
immunohistochemistry hierarchical
4
clustering defined
4
defined signatures
4
tissue muscle-invasive
4
differentiated cancer
4
expression validated
4
muscle-invasive non-muscle
4
tissue grade
4
grade grade
4

Keyword Occurance

Similar Publications

Intravesical combination therapies for non-muscle invasive bladder cancer: Recent advances and future directions.

Authors:
You Li Shams F Youssef Asma Bm Buanz

Eur J Pharmacol 2022 May 14:175024. Epub 2022 May 14.

Department of Pharmaceutics, School of Pharmacy, University College London, UK. Electronic address:

Bladder cancer is the 10th most frequently diagnosed cancer worldwide with 5-year survival rate around 70%. The current first-line treatment for non-muscle invasive bladder cancer is transurethral resection of bladder tumours followed by intravesical Mycobacterium Bovis Bacillus Calmette-Guérin (BCG) immunotherapy. However, tumor recurrence rate is still high ranging from 31% to 78% within five years. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Two cases of Bacillus Calmette-Guérin cystitis treated with hyperbaric oxygen.

Authors:
Gerald H Markovitz

Undersea Hyperb Med 2022 Second Quarter;49(2):191-195

UCLA Hyperbaric Medicine, Los Angeles, California U.S.

Hyperbaric oxygen (HBO2) therapy is a UHMS-approved treatment for radiation cystitis and has been used for other causes of cystitis such as cyclophosphamide-induced hemorrhagic cystitis and interstitial cystitis, among others. Immunotherapy with Bacillus Calmette-Guérin (BCG) is the most effective treatment of non-muscle invasive bladder cancer. BCG acts as a non-specific stimulant of the reticuloendothelial system, causing a local inflammatory response. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Attribution of Cancer Origins to Endogenous, Exogenous, and Preventable Mutational Processes.

Authors:
Vincent L Cannataro Jeffrey D Mandell Jeffrey P Townsend

Mol Biol Evol 2022 May;39(5)

Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT, USA.

Mutational processes in tumors create distinctive patterns of mutations, composed of neutral "passenger" mutations and oncogenic drivers that have quantifiable effects on the proliferation and survival of cancer cell lineages. Increases in proliferation and survival are mediated by natural selection, which can be quantified by comparing the frequency at which we detect substitutions to the frequency at which we expect to detect substitutions assuming neutrality. Most of the variants detectable with whole-exome sequencing in tumors are neutral or nearly neutral in effect, and thus the processes generating the majority of mutations may not be the primary sources of the tumorigenic mutations. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Automatic contouring QA method using a deep learning-based autocontouring system.

Authors:
Dong Joo Rhee Chidinma P Anakwenze Akinfenwa Bastien Rigaud Anuja Jhingran Carlos E Cardenas Lifei Zhang Surendra Prajapati Stephen F Kry Kristy K Brock Beth M Beadle William Shaw Frederika O'Reilly Jeannette Parkes Hester Burger Nazia Fakie Chris Trauernicht Hannah Simonds Laurence E Court

J Appl Clin Med Phys 2022 May 17:e13647. Epub 2022 May 17.

Department of Radiation Physics, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Purpose: To determine the most accurate similarity metric when using an independent system to verify automatically generated contours.

Methods: A reference autocontouring system (primary system to create clinical contours) and a verification autocontouring system (secondary system to test the primary contours) were used to generate a pair of 6 female pelvic structures (UteroCervix [uterus + cervix], CTVn [nodal clinical target volume (CTV)], PAN [para-aortic lymph nodes], bladder, rectum, and kidneys) on 49 CT scans from our institution and 38 from other institutions. Additionally, clinically acceptable and unacceptable contours were manually generated using the 49 internal CT scans. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Therapeutic potentials of genistein: New insights and perspectives.

Authors:
Sumbal Rasheed Kanwal Rehman Momina Shahid Shaleem Suhail Muhammad Sajid Hamid Akash

J Food Biochem 2022 May 17:e14228. Epub 2022 May 17.

Department of Pharmaceutical Chemistry, Government College University, Faisalabad, Pakistan.

Genistein, a polyphenolic isoflavone compound found abundantly in soy or soy-based products, is widely consumed in the Asian population. Genistein has poor bioavailability, to overcome this problem many advanced nano-drug delivery carrier systems are designed to enhance its water solubility and stability. However, further research is required to develop more efficient bioavailability improvement strategies. Read More

View Article and Full-Text PDF
May 2022
Similar Publications
}
© 2022 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap